Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 26.13
- Piotroski Score 4.00
- Grade Outperform
- Symbol (TERN)
- Company Terns Pharmaceuticals, Inc.
- Price $7.09
- Changes Percentage (2.16%)
- Change $0.15
- Day Low $6.71
- Day High $7.34
- Year High $11.40
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical trial for the treatment of NASH; and TERN-201, a vascular adhesion protein-1 inhibitor that is in Phase Ib clinical trial for the treatment of NASH. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase I clinical trial for the treatment of NASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for NASH and metabolic diseases, such as obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/12/2024
- Fiscal Year End N/A
- Average Stock Price Target $12.00
- High Stock Price Target $26.00
- Low Stock Price Target $7.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.26
- Trailing P/E Ratio -5.67
- Forward P/E Ratio -5.67
- P/E Growth -5.67
- Net Income $-90,210,000
Income Statement
Quarterly
Annual
Latest News of TERN
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Moldova's pro-Western president wins 2nd term in runoff overshadowed by Russian meddling claims
Moldova's President Maia Sandu won a second term in a key runoff against a Russia-backed opponent amid allegations of interference. Sandu's victory signals continued pro-Western policies, with EU supp...
By NBC News | 1 day ago -
Moldova's pro-Western Sandu claims election win after meddling allegations
By Tom Balmforth and Alexander TanasCHISINAU (Reuters) -Moldova's pro-Western incumbent Maia Sandu claimed victory at Sunday's closely-fought presidential election, defeating Alexandr Stoianoglo, her ...
By Reuters | 1 day ago -
Australia v Pakistan: first men's one-day international - live
Welcome to the Guardian's live coverage of the first men's one-day international between Australia and Pakistan at the Melbourne Cricket Ground. Angus Fontaine will guide you through this exciting mat...
By The Guardian | 1 day ago
